Although its role in breast cancer has not been reported yet, one study demonstrated that in hepatocellular carcinoma, downregulation of MRPL13 was a key factor of mitoribosome regulation and subsequent OXPHOS defects, and regulated hepatoma cell invasion [39]. This evidence concerns the gene MRPL13 and breast cancer.